MedTrace Logo

General Practice Research Database Seroquel XR Safety Study

NCT01447082 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37372

Last updated 2014-02-07

No results posted yet for this study

Summary

The main objective of this observational study is to characterize new users of quetiapine XR as well as new users of other study drugs (i.e. the comparison group) and to quantify the risk of developing newly diagnosed outcomes of interest in new users of quetiapine XR as well as in other study drugs.

Conditions

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    collaborator OTHER

  • AstraZeneca

    lead INDUSTRY

Principal Investigators

  • Christoph R Meier, PROF DR PHIL · University hospital of Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01447082 on ClinicalTrials.gov